CTF-01 Published on September 3, 2020 in TINT: A phase II study of trametinib in paediatric, adolescent and young adult patients with Neurofibromatosis type 1 associated plexiform neurofibromas or progressive optic pathway gliomas. Full resolution (913 × 671)